CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
Effect of mucosal cytokine administration on selective expansion of vaginal dendritic cells to support nanoparticle transport
-
10 2015
-
-
Source: Am J Reprod Immunol. 74(4):333-344
[PDF-1.11 MB]
Details:
-
Alternative Title:Am J Reprod Immunol
-
Personal Author:
-
Description:Problem
The capacity of antigen-carrying vaccine nanoparticles administered vaginally to stimulate local immune responses may be limited by the relatively low numbers of antigen-presenting cells (APCs) in the genital mucosa. Because inflammation is associated with increased susceptibility to sexually transmitted infections, we sought to increase APC numbers without causing inflammation.
Method of Study
In this study, we evaluated intravaginal delivery of chemokines, growth factors, or synthetic adjuvants to expand APCs in reproductive tissues.
Results
We found that granulocyte macrophage-colony stimulating factor (GM-CSF) stimulated expansion of CD11b+ dendritic cells within 24 h of intravaginal administration, with no effect on Langerhans cells or macrophages. Expansion of the CD11b+ DC population was not associated with increased inflammatory cytokine production, and these cells retained phagocytic function.
Conclusion
Our data suggest that non-inflammatory expansion of mucosal APCs by intravaginal GM-CSF could be used as an adjuvanting strategy to potentiate the genital immune response to nanoparticulate mucosal vaccines.
-
Subjects:
-
Keywords:
-
Source:
-
Pubmed ID:26118309
-
Pubmed Central ID:PMC4599983
-
Document Type:
-
Funding:
-
Volume:74
-
Issue:4
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
